MacroGenics, Inc. (MGNX)
3.075
-0.12
(-3.61%)
USD |
NASDAQ |
Apr 27, 14:28
MacroGenics EPS Diluted (Quarterly) : -0.2236 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Gilead Sciences, Inc. | 1.742 |
| SIGA Technologies, Inc. | -0.0758 |
| BioLife Solutions, Inc. | 0.0152 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.16M |
| Revenue (Quarterly) | 41.23M |
| Total Expenses (Quarterly) | 55.38M |
| Enterprise Value | 119.59M |
| Gross Profit Margin (Quarterly) | 71.33% |
| Profit Margin (Quarterly) | -34.33% |
| Earnings Yield | -38.49% |
| Normalized Earnings Yield | -38.49 |